China’s state-run Xinhua News Agency reports that
healthcare providers at Wuhan’s Jinyintan Hospital will begin treating
the first group of severe coronavirus cases with Gilead Sciences’ (GILD -2.2%) remdesivir tomorrow. A total of 761 patients will receive therapy.
Chinese authorities have OK’d the start of clinical trials.
https://seekingalpha.com/news/3538631-testing-of-gileads-remdesivir-in-coronavirus-patients-to-start-tomorrow-in-china
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.